Varian Biopharmaceuticals to Present at the Inflection Partners "Excellence in Execution" Conference on November 16th and 17thVarian Biopharmaceuticals is Developing a Proprietary atypical Protein Kinase C iota Inhibitor in Multiple Formulations for A Broad Range of Tumor Types
NAPLES, Fla. - Nov. 15, 2021 - PRLog -- Varian Biopharmaceuticals, Inc. ("VarianBio"), a private, precision oncology company developing novel therapeutics for the treatment of cancer, today announced its President and CEO, Jeffrey Davis, will be presenting at the Inflection Partners Fall Investment Conference entitled "Excellence in Execution."
The Inflection Partners Fall Conference will take place virtually on November 16-17, 2021, and Mr. Davis is scheduled to present at 2:40 pm ET on Tuesday, November 16, 2021. To register for the Inflection Partners conference, please visit: www.inflectionpartnersllc.com/ This event will feature more than 25 companies, ranging from disruptive seed stage startups to $1bn+ market cap public companies. This year's conference supports the Travis Manion Foundation (TSF), which strives to unite and strengthen communities by training, developing, and highlighting the role models that lead them. Travis Manion was an experienced and decorated Marine who was killed in action on April 29, 2007, in Iraq. The TSF develops programs, training opportunities, and events designed to empower veterans and families of the fallen while inspiring them to pass their values on to the next generation and the community at large. For more information, please visit travismanion.org. About Varian Biopharmaceuticals, Inc. Varian Biopharmaceuticals, Inc. ("VarianBio") Forward-Looking Statements – Safe Harbor Statement Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements, which involve assumptions and describe the Company's future plans, strategies and expectations, are generally identifiable by use of the words "may," "should," "would," "will," "could," "scheduled," Contacts: Investors and Media Jeffrey B. Davis President & CEO jdavis@varianbio.com Contact media@varianbio.com End
Account Email Address Account Phone Number Disclaimer Report Abuse |